June 17, 2024

Animal Vaccine Market Size To Cross USD 36.91 Bn By 2032

The global animal vaccine market size accounted for US$ 14.27 Bn in 2022 and is projected to reach around USD 36.91 Bn by 2032, growing at a CAGR of 9.97% from 2023 to 2032.

Animal Vaccine Market Size 2023 To 2032

Report Summary

The global animal vaccine market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the animal vaccine market across the globe.

A comprehensive estimate on the animal vaccine market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of animal vaccine during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2958

Animal Vaccine Market Report Scope 

Report CoverageDetails
Market Size in 2023USD 15.69 Billion
Market Size by 2032USD 36.91 Billion
Growth Rate from 2023 to 2032CAGR of 9.97%
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Product Type, By Animal Type, By Route of Administration, and By End User
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized animal vaccine market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read:  Smart Sensors Market Size To Cross USD 231.04 Bn By 2032

Animal Vaccine Market  Players

The report includes the profiles of key animal vaccine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Merck & Co., Inc.
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Biogénesis Bagó
  • Indian Immunologicals Ltd.
  • Elanco
  • Ceva
  • Phibro Animal Health Corporation
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Ourofino Saúde Animal

Market Segmentation

By Product Type

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

By Animal Type

  • Livestock
    • Poultry
    • Aqua
    • Ruminants
    • Swine
  • Companion
    • Canine
    • Feline

By Route of Administration

  • Subcutaneous
  • Intramuscular
  • Intranasal

By End User

  • Hospital
  • clinics

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Animal Vaccine Market 

5.1. COVID-19 Landscape: Animal Vaccine Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Animal Vaccine Market, By Product Type

8.1. Animal Vaccine Market Revenue and Volume Forecast, by Product Type, 2023-2032

8.1.1. Attenuated Live Vaccines

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Inactivated Vaccines

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Subunit Vaccines

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. DNA Vaccines

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

8.1.5. Recombinant Vaccines

8.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Animal Vaccine Market, By Animal Type

9.1. Animal Vaccine Market Revenue and Volume Forecast, by Animal Type, 2023-2032

9.1.1. Livestock

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Companion

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Animal Vaccine Market, By Route of Administration 

10.1. Animal Vaccine Market Revenue and Volume Forecast, by Route of Administration, 2023-2032

10.1.1. Subcutaneous

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Intramuscular

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Intranasal

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Animal Vaccine Market, By End User 

11.1. Animal Vaccine Market Revenue and Volume Forecast, by End User, 2023-2032

11.1.1. Hospital

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. clinics

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Animal Vaccine Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

Chapter 13. Company Profiles

13.1. Merck & Co., Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Zoetis

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Boehringer Ingelheim International GmbH

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Virbac

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Biogénesis Bagó

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Indian Immunologicals Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Elanco

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Ceva

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Phibro Animal Health Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Neogen Corporation

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com